doi: 10.1016/0753-3322(91)90067-4.
Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM)
Affiliations
- PMID: 1773025
- DOI: 10.1016/0753-3322(91)90067-4
Item in Clipboard
Effects of metformin on haemorheology, lipid parameters and insulin resistance in insulin-dependent diabetic patients (IDDM)
Biomed Pharmacother.
1991.
Abstract
We have evaluated the effect of metformin on haemorheology, lipid levels and insulin resistance in insulin-dependent diabetic patients over a 6-week period. Rheological parameters remained unaltered except for the whole blood clogging rate which decreased significantly. No effect on lipid levels was seen. The main effect of metformin was limited to daily insulin requirement and insulin units/kg bw. Bearing in mind the negative effects of high insulin levels, metformin could be useful in the prevention of atherogenesis in insulin-dependent diabetic patients.
Similar articles
-
Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.Dan Med Bull. 2002 Feb;49(1):43-60. Dan Med Bull. 2002. PMID: 11894723 Review.
-
Treatment with a novel agent combining docosahexaenoate and metformin increases protectin DX and IL-6 production in skeletal muscle and reduces insulin resistance in obese diabetic db/db mice.Diabetes Obes Metab. 2017 Mar;19(3):313-319. doi: 10.1111/dom.12818. Epub 2016 Dec 9. Diabetes Obes Metab. 2017. PMID: 27800648
-
Effect of Metformin Therapy on Serum Fetuin Levels in Insulin Resistant Type 1 Diabetics.Curr Diabetes Rev. 2018;14(3):291-297. doi: 10.2174/1573399813666170112151108. Curr Diabetes Rev. 2018. PMID: 28081696 Clinical Trial.
-
Effect of metformin and rosiglitazone on lipid metabolism in HIV infected patients receiving protease inhibitor containing HAART.Acta Dermatovenerol Alp Pannonica Adriat. 2005 Sep;14(3):99-105. Acta Dermatovenerol Alp Pannonica Adriat. 2005. PMID: 16200335 Clinical Trial.
-
[Glucose toxicity--pros and cons. Useful adaptation and common cause of insulin resistance in diabetic patients].Nord Med. 1996 Mar;111(3):80-3. Nord Med. 1996. PMID: 8628644 Review. Swedish.
Cited by
-
Metformin added to insulin therapy for type 1 diabetes mellitus in adolescents.Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD006691. doi: 10.1002/14651858.CD006691.pub2. Cochrane Database Syst Rev. 2009. PMID: 19160294 Free PMC article.
-
Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.Drugs. 1995 May;49(5):721-49. doi: 10.2165/00003495-199549050-00007. Drugs. 1995. PMID: 7601013 Review.
-
The use of metformin in type 1 diabetes: a systematic review of efficacy.Diabetologia. 2010 May;53(5):809-20. doi: 10.1007/s00125-009-1636-9. Epub 2010 Jan 8. Diabetologia. 2010. PMID: 20057994
-
Combined therapy with metformin and insulin attenuates systemic and hepatic alterations in a model of high-fat diet-/streptozotocin-induced diabetes.Int J Exp Pathol. 2016 Jun;97(3):266-77. doi: 10.1111/iep.12184. Epub 2016 Jul 6. Int J Exp Pathol. 2016. PMID: 27381700 Free PMC article.
-
Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.PLoS One. 2008;3(10):e3363. doi: 10.1371/journal.pone.0003363. Epub 2008 Oct 9. PLoS One. 2008. PMID: 18852875 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
